“Nobody is reading any of those essays you caregivers write,” a healthcare provider once told me. The following week, a stranger emailed me: “Your…
Myeloma
One-third of patients with hard-to-treat myeloma were alive and free from disease progression five years after a single infusion of the cell therapy Carvykti…
When I recently read that former U.S. President Joe Biden had been diagnosed with prostate cancer and it had spread to his bones, my heart…
A committee of the European Medicines Agency has recommended approving GSK’s Blenrep (belantamab mafodotin) in combination with other therapeutic agents to treat relapsed or refractory…
I wanted to scream at my mother last Tuesday when she insisted on skipping her medication because she didn’t feel like taking it. While she…
A U.S. Food and Drug Administration (FDA) committee has voted in favor of Darzalex Faspro (daratumumab and hyaluronidase-fihj) to treat high-risk smoldering multiple myeloma…
I’ll never forget the day that my mother was diagnosed with myeloma. That was when the word “son” was entirely erased from my identity.
Nearly all the people with relapsed or refractory multiple myeloma (RRMM) who took part in a Phase 2 clinical trial responded to the cell…
The U.S. Food and Drug Administration (FDA) has granted fast track status to ISB 2001, an experimental therapy for difficult-to-treat multiple myeloma. The designation…
The European Commission (EC) has conditionally approved Regeneron Pharmaceuticals’ linvoseltamab, now Lynozyfic, to treat adults with relapsed or refractory multiple myeloma (RRMM).
